Jashin Wu
Dermatology · Corona, CANPI 1407953102
Payments from drug & device makers
Across 1,672 payments — averaging $1353.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$734K
- Sun Pharmaceutical Industries Inc.$304K
- Pfizer$233K
- Amgen$140K
- Bristol Myers Squibb$132K
- Novartis$114K
- plus $608K from 43 others
Across 46 payments — averaging $1000.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$11K
- Regeneron$11K
- Pfizer$10K
- Novartis$9K
- UCB, Inc.$2K
- Sanofi$1K
- plus $2K from 2 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,262,961 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Other dermatology in Corona
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
- April ArmstrongLos Angeles$6.2M
- David RayhanHuntington Beach$5.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.